Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

OBJECTIVE: The management of cardiotoxicity concerning the use of oral antineoplastic agents (OAAs) is a challenge for healthcare professionals. Our objective was to create a comprehensive medication management guide with dose adjustment recommendations on OAAs concerning cardiotoxic and lipid metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Ruperez, Elena, Escudero-Vilaplana, Vicente, Ruiz-Briones, Paula, Collado-Borrell, Roberto, Villanueva-Bueno, Cristina, Revuelta-Herrero, José Luis, González-Haba, Eva, Garcia-Gonzalez, Xandra, Ibañez-Garcia, Sara, Perez-Ramirez, Sara, Zatarain-Nicolás, Eduardo, Herranz, Ana, Sanjurjo, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485602/
https://www.ncbi.nlm.nih.gov/pubmed/37692846
http://dx.doi.org/10.3389/fonc.2023.1220305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485602/
https://www.ncbi.nlm.nih.gov/pubmed/37692846
http://dx.doi.org/10.3389/fonc.2023.1220305

Ejemplares similares